MAPK3 and ischemic stroke: Our study strongly supports the hypothesis that the activation of ERK1/2 in ischemic stroke can cause massive damage, as shown, for example, by the huge infarct size that extends even to the contralateral hemisphere and by the significantly impaired neurological function after tMCAO.